ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.016,75
0,55%
S&P 500
6.049,88
0,05%
Dow Jones
44.705,53
-0,17%
Euro vs US Dollar
1,05103
0,00%
Bitcoin
96.175,07
0,21%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. International Stem Cell Corporation (QB) (ISCO)

  7. International Stem Cell Corporation (QB) (ISCO) News

ISCO

International Stem Cell (QB) (ISCO)

International Stem Cell Corporation (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:ISCO
DatumZeitQuelleÜberschriftSymbolFirma
13/11/202422h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ISCOInternational Stem Cell Corporation (QB)
13/08/202422h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ISCOInternational Stem Cell Corporation (QB)
13/06/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ISCOInternational Stem Cell Corporation (QB)
14/05/202422h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ISCOInternational Stem Cell Corporation (QB)
13/11/202322h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ISCOInternational Stem Cell Corporation (QB)
08/11/202319h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ISCOInternational Stem Cell Corporation (QB)
08/11/202319h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ISCOInternational Stem Cell Corporation (QB)
27/09/202318h27Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsUSOTC:ISCOInternational Stem Cell Corporation (QB)
18/09/202314h01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ISCOInternational Stem Cell Corporation (QB)
11/08/202320h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ISCOInternational Stem Cell Corporation (QB)
21/06/202320h08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
16/06/202323h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
12/05/202322h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
28/04/202322h31Edgar (US Regulatory)Annual Report to Security Holders (ars)USOTC:ISCOInternational Stem Cell Corporation (QB)
30/03/202322h37Edgar (US Regulatory)Annual Report (10-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
16/03/202319h14Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
14/11/202222h05Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
12/08/202221h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
14/06/202212h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
10/06/202223h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
10/06/202223h02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
13/05/202217h55Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
29/04/202213h52Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
27/04/202222h32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ISCOInternational Stem Cell Corporation (QB)
27/04/202200h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
29/03/202222h38Edgar (US Regulatory)Annual Report (10-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
03/03/202222h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
12/11/202122h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
01/11/202121h44Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
13/08/202122h03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
 Showing the most relevant articles for your search:USOTC:ISCO

Kürzlich von Ihnen besucht

NYSE
DIS
Walt Disney
TG
TUI1
Tui
TG
DTE
Deutsche Telekom
CCOM
US30
US 30
USOTC
BASFY
BASF (QX)
TG
CBK
Commerzbank
USOTC
RHHBY
Roche (QX)
TG
432
Arbor Metals
NASDAQ
MSFT
Microsoft
AMEX
XLE
Energy Select Sector SPDR
NYSE
XOM
Exxon Mobil
COIN
ETHUSD
Ethereum
USOTC
BNPQY
BNP Paribas (QX)
NYSE
KO
Coca Cola
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten